Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (NNFN) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NNFNMannKindCHF 3.46CHF 1.10B-17.282.00%Strong BuyUnlock the CH:NNFN analyst price target with TipRanks PremiumCH:NNFNUnlock the CH:NNFN top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.72$765.80M-11.8417.01%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumCH:NNFN vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.40$1.31B7.24-15.87%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumCH:NNFN vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.72$1.04B-7.7413.19%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumCH:NNFN vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.99$3.10B-423.69139.97%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumCH:NNFN vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NNFNMannKind3.460.072.00%
LXRXLexicon Pharmaceuticals1.720.2718.62%
INVAInnoviva18.40-2.87-13.49%
SVRASavara4.720.122.61%
XERSXeris Pharmaceuticals16.999.90139.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts